Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-22-001333
Filing Date
2022-02-10
Accepted
2022-02-10 09:01:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 AEGLEA BIOTHERAPEUTICS, INC. p22-0512sc13ga.htm SC 13G/A 103324
  Complete submission text file 0000902664-22-001333.txt   104955
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

EIN.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 22611353
SIC: 2834 Pharmaceutical Preparations